fidaxomicin

The newly issued patent and a previously issued patent encompassing fidaxomicin are both orange book listable.

Optimer Pharmaceuticals Obtains Additional Fidaxomicin Patent - Yahoo! Finance 2011

Optimer has filed marketing applications in the U.S. and the EU for fidaxomicin for the treatment of CDI and for the prevention of recurrences.

Optimer Pharmaceuticals Obtains Additional Fidaxomicin Patent - Yahoo! Finance 2011

The new drug, known generically as fidaxomicin, is only the third antibiotic cleared by the FDA since 2006, according to Optimer.

The Seattle Times 2011

Optimer has two anti-infective product candidates in development, fidaxomicin and Pruvel™ prulifloxacin.

Optimer Pharmaceuticals Obtains Additional Fidaxomicin Patent - Yahoo! Finance 2011

Also during the quarter, the company announced the signing of an exclusive two-year co-promotion agreement with Optimer Pharmaceuticals to market DIFICID™ fidaxomicin tablets, in the United States.

unknown title 2011

The new drug, known generically as fidaxomicin, is only the third antibiotic cleared by the FDA since 2006, according to Optimer.

The Seattle Times 2011

Optimer has developed and is commercializing DIFICID™ fidaxomicin tablets, an FDA-approved antibacterial drug for the treatment of adult patients with

unknown title 2011

Optimer has filed a marketing authorization application with the European Medicines Agency for fidaxomicin.

unknown title 2011

The drug called DIFICLIR, or fidaxomicin, was approved for use in the U.S. by the FDA in May.

unknown title 2011

This patent further strengthens Optimer's patent protection for fidaxomicin.

Optimer Pharmaceuticals Obtains Additional Fidaxomicin Patent - Yahoo! Finance 2011